Kemwell Biopharma

Kemwell Biopharma
Product Description

SERVICES Kemwell provides integrated development and manufacturing services for companies that require one-stop solution for mammalian cell-culture based protein therapeutics The team is experienced to undertake end-to-end activities right from cell line development till cGMP clinical and commercial manufacturing. Kemwell also undertakes standalone projects such as process optimisation, analytical method development or validation, formulation development and optimization, stability studies, resin reuse study, tech transfer and cGMP manufacturing, process characterization, etc.

Read more Show less

Kemwell Biopharma

  • IN
  • 2021
    On CPHI since
View company profile
Categories
more categories Show less
Sales Markets
Show more Show less

Kemwell Biopharma

  • IN
  • 2021
    On CPHI since
View company profile

More Products from Kemwell Biopharma (4)

  • Kemwell Biopharma - Analytical Development

    Product Kemwell Biopharma - Analytical Development

    - Method development, qualification and validation services. - Platform methodologies - Offers as part of integrated or standalone service - Tests performed in-house for in-process and release, including in vitro bioassay and sterility, endotoxin.
  • Kemwell Biopharma - Formulation Development

    Product Kemwell Biopharma - Formulation Development

    - Pre-formulation Studies - Formulation Screening Studies - Lyophilization Cycle Development
  • Kemwell Biopharma - Process Development

    Product Kemwell Biopharma - Process Development

    Process Development - AMBR®250, Shake flasks, 5L, 10L (glass bioreactors), 50L (SUB), 80L (SS) – adaptable to support perfusion systems - Non-GLP and GLP tox material generation - Well characterized and geometrically similar bioreactors in pilot and GMP facility - Integrated with analytical development and...
  • Why Kemwell Services ?

    Product Why Kemwell Services ?

    -Integrated Service Provider – Drug Substance and Drug Product -Diverse experience – monoclonal antibodies, complex fusion proteins, recombinant proteins and bispecific antibodies -First CDMO in India licensed to manufacture commercial DS -4 years accomplishments – 7 projects in process development, 6 clin...

Kemwell Biopharma resources (4)